Francisco Sierra is a Cardiology physician. OpenAlex indexes 12 publications with 839 citations (h-index 4); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
499 Gloster Creek Vlg Ste A2
Cardiology Associates Of North Ms
Tupelo, MS 388014749
Telephone
662-620-6800Registry record last updated 28 Jun 2011.
Clinical trials
- IV Dexmedetomidine in the Duration of Spinal Anesthesia With Hyperbaric Bupivacaine: Double Blind Randomized Trial.
Sponsor: Hospital Central "Dr. Ignacio Morones Prieto"
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
9 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- LANTHEUS MEDICAL IMAGING, INC.Program year20241 payment
- ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)Program year20241 payment
- Merck Sharp & Dohme LLCProgram year20222 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
100%Beta blocker51%Metoprolol Succinate52%Carvedilol48%Part D<11 patientsNitrate26.5%Isosorbide Dinitrate100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Hands-On or Gloved Approach? Unveiling Patient Experiences in Orthopaedic Foot and Ankle Clinics
Foot & Ankle Specialist
2025 - Is Discharging Patients After External Fixation and Between Stages During Periarticular Lower Extremity Fracture Care Safe?
Journal of Orthopaedic Trauma
2025 - Hands-on or Gloved Approach? Unveiling Patient Experiences in Orthopaedic Foot and Ankle Clinics
Foot & Ankle Orthopaedics
2024 - Safety and Efficacy of Renal Denervation in Patients Taking Antihypertensive Medications
Journal of the American College of Cardiology
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”